GLOBAL BIO-CHEM(00809) intends to carry out a stock consolidation plan entitled "10-to-1" and change the minimum trading unit per lot.
Da Cheng Biochemical Technology (00809) announced that the board of directors has recommended implementing a stock consolidation, with the following criteria: (i) every 10 existing issued and unissued shares with a face value of HK$0.10 each will be consolidated into 1 share with a face value of HK$1.00 each; (ii) every 10 existing issued and unissued convertible preferred shares with a face value of HK$0.10 each will be consolidated into 1 share with a face value of HK$1.00 each.
GLOBAL BIO-CHEM (00809) announced that the board of directors has proposed a stock consolidation, with the following terms: (i) every 10 existing shares, with a par value of HK$0.10 per share, will be consolidated into 1 share with a par value of HK$1.00; (ii) every 10 existing convertible preferred shares, with a par value of HK$0.10 per share, will be consolidated into 1 convertible preferred share with a par value of HK$1.00.
As of the date of this announcement, the existing shares are traded on the Stock Exchange of Hong Kong in units of 2000 shares. Subject to and upon the effectiveness of the stock consolidation, it is proposed to change the trading unit on the Stock Exchange of Hong Kong from 2000 shares of existing shares to 10,000 shares of consolidated shares.
Related Articles

JINHAI MED TECH (02225) announced its annual performance, with a net loss of 17.08 million Singapore dollars attributable to shareholders, a decrease of 4.9% year-on-year.

RIZHAO PORT JR (06117) Announces Annual Performance Net Profit of 171 million RMB Decreased by 17.03% Year-on-Year.

SICC Co., Ltd. (02631) achieved a total revenue of approximately 1.465 billion yuan in 2025, continuing to increase research and development expenses to consolidate its leading position in the industry against the trend.
JINHAI MED TECH (02225) announced its annual performance, with a net loss of 17.08 million Singapore dollars attributable to shareholders, a decrease of 4.9% year-on-year.

RIZHAO PORT JR (06117) Announces Annual Performance Net Profit of 171 million RMB Decreased by 17.03% Year-on-Year.

SICC Co., Ltd. (02631) achieved a total revenue of approximately 1.465 billion yuan in 2025, continuing to increase research and development expenses to consolidate its leading position in the industry against the trend.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


